Literature DB >> 19238167

Functional analysis of a mutation in the SLCO1B1 gene (c.1628T>G) identified in a Japanese patient with pravastatin-induced myopathy.

Tomomi Furihata1, Naoki Satoh, Tomoharu Ohishi, Miyuki Ugajin, Yoshio Kameyama, Kaori Morimoto, Sayaka Matsumoto, Keiko Yamashita, Kaoru Kobayashi, Kan Chiba.   

Abstract

In the present study, we analyzed the function of a novel mutation (c.1628T>G, p.Leu543Trp) in the solute carrier organic anion transporter (SLCO) 1B1 gene, encoding organic anion transporting polypeptide (OATP) 1B1, which was identified in a patient with pravastatin-induced myopathy. OATP1B1 variants carrying the mutation (OATP1B1*1a+c.1628T>G or *1b+c.1628T>G) showed a reduced transporting activity toward typical substrates and pravastatin compared with the activity of the references (OATP1B1*1a or *1b). This was due to reduction in V(max) values of the variants, not due to change in their K(m) values. OATP1B1*1b+c.1628T>G was normally expressed on the plasma membrane of HEK293 cells at the same level as that of OATP1B1*1b. Taken together, our results suggest that the mutation c.1628T>G (p.Leu543Trp) reduced the function of OATP1B1 probably due to decrease in turnover rate of one OATP1B1 molecule rather than impairment of protein sorting to the plasma membrane.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19238167     DOI: 10.1038/tpj.2009.3

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN: 1470-269X            Impact factor:   3.550


  10 in total

Review 1.  Drug-induced cholestasis.

Authors:  Manmeet S Padda; Mayra Sanchez; Abbasi J Akhtar; James L Boyer
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

2.  Influence of SLCO1B1 polymorphisms on lopinavir Ctrough in Serbian HIV/AIDS patients.

Authors:  Gordana Dragović; Božana Dimitrijević; Jovana Kušić; Ivan Soldatović; Djordje Jevtović; Adeniyi Olagunju; Andrew Owen
Journal:  Br J Clin Pharmacol       Date:  2020-02-28       Impact factor: 4.335

3.  Different interaction profiles of direct-acting anti-hepatitis C virus agents with human organic anion transporting polypeptides.

Authors:  Tomomi Furihata; Shogo Matsumoto; Zhongguo Fu; Akihito Tsubota; Yuchen Sun; Sayaka Matsumoto; Kaoru Kobayashi; Kan Chiba
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

Review 4.  Update on toxic myopathies.

Authors:  F L Mastaglia; M Needham
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

Review 5.  Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutions.

Authors:  QiPing Feng; Russell A Wilke; Tesfaye M Baye
Journal:  Pharmacogenomics       Date:  2012-04       Impact factor: 2.533

6.  Unique expression features of cancer-type organic anion transporting polypeptide 1B3 mRNA expression in human colon and lung cancers.

Authors:  Yuchen Sun; Tomomi Furihata; Seiya Ishii; Miki Nagai; Manami Harada; Osamu Shimozato; Takehiko Kamijo; Shinichiro Motohashi; Ichiro Yoshino; Atsuko Kamiichi; Kaoru Kobayashi; Kan Chiba
Journal:  Clin Transl Med       Date:  2014-11-18

Review 7.  Association between SLCO1B1 -521T>C and -388A>G polymorphisms and risk of statin-induced adverse drug reactions: A meta-analysis.

Authors:  Jiajia Jiang; Qing Tang; Jing Feng; Rong Dai; Yang Wang; Yuan Yang; Xiaojun Tang; Changkai Deng; Huan Zeng; Yong Zhao; Fan Zhang
Journal:  Springerplus       Date:  2016-08-19

8.  The Effect of Single Nucleotide Variations in the Transmembrane Domain of OATP1B1 on in vitro Functionality.

Authors:  Wilma Kiander; Kati-Sisko Vellonen; Melina M Malinen; Mikko Gynther; Marja Hagström; Madhushree Bhattacharya; Seppo Auriola; Jan B Koenderink; Heidi Kidron
Journal:  Pharm Res       Date:  2021-10-13       Impact factor: 4.200

9.  Pharmacogenomic insights into treatment and management of statin-induced myopathy.

Authors:  Bas Jm Peters; Olaf H Klungel; Frank L Visseren; Anthonius de Boer; Anke-Hilse Maitland-van der Zee
Journal:  Genome Med       Date:  2009-12-29       Impact factor: 11.117

10.  Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.

Authors:  Xutao Deng; Ester C Sabino; Edecio Cunha-Neto; Antonio L Ribeiro; Barbara Ianni; Charles Mady; Michael P Busch; Mark Seielstad
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.